Bioactivity of Nano Curcuma longa Encapsulated in Carboxymethyl Chitosan

Document Type

Article

Publication Date

1-1-2026

Abstract

Nanoencapsulation of C. longa extract with carboxymethyl chitosan (CMCs) was formulated to prevent its bioactive deterioration in anti-dengue and anticancer activities. The particle size of Cl-NPs was measured at 462.5 ± 10.87 nm with a PDI value of 0.28 ± 0.05 which indicates homogeneous particle size distribution. Cl-NPs were observed to be stable at 30-100° C but less stable at high pH and salt concentrations. Cl-NPs had a %LE of 19.77 ± 7.46% and %LC of 39.54 ± 14.91%. The release of Cl-NPs at pH 2, was observed at 2.89 ± 0.33%; at pH 7, it was 8.50 ± 0.98%; and at pH 8.5, it was 5.89 ± 0.40%. The best release was observed at pH 7. Anticancer activity against the MCF-7 cell line showed that Cl-NPs had better inhibitory activity compared to C. longa. Cl-NPs had an EC50 value of 4.75 ± 0.42 µg/mL, while C. longa had 33.03 ± 7.20 µg/mL. C. longa extract and Cl-NPs exhibited anti-dengue activity with EC50 values of 54.09 ± 11.84 and 9.02 ± 0.00 µg/mL, respectively. Based on the selectivity index (SI), Cl-NPs are more selective than the C. longa extract. Proven to improve bioavailability and controlled release, C. longa extract nanoencapsulation enables precise targeting of bioactive compounds to enhance bioactivity.

Keywords

Anticancer, Antivirus, Breast cancer, CMC, DENV, Nanocurcumin

Publication Title

Advanced Journal of Chemistry Section A

ISSN

26457768

DOI

10.48309/ajca.2026.536045.1891

Volume

9

Issue

1

First Page

134

Last Page

145

Share

COinS